PlatinumRx Helps Indians Save Rs. 137 Crore, Expands Affordable Medicine Access Nationwide
PlatinumRx has helped customers save more than Rs. 137 crore through affordable branded generic medicines while expanding deliveries to over 19,000 PIN codes across India. The company is strengthening its nationwide reach with new warehouses and quality-focused healthcare solutions.
Founded in September 2023 by Ashutosh Pandey and Piyush Kumar, IIT and IIM alumni, PlatinumRx was established with the mission of making quality medicines affordable without compromising on safety, efficacy, or trust. Since commencing operations in early 2024, the company has rapidly expanded its presence by providing clinically equivalent branded generic medicines at significantly lower prices than many conventional brands.
The platform is focused on addressing the financial burden faced by millions of Indians living with chronic conditions such as diabetes, hypertension, heart disease, thyroid disorders, and other long-term illnesses. As medicines for these conditions represent a recurring monthly expense rather than a one-time purchase, PlatinumRx offers quality-assured branded generic alternatives that enable patients to reduce their medicine costs while continuing their prescribed treatment without compromising on quality or manufacturing standards.
"Healthcare should never become unaffordable because of medicine costs," said Ashutosh Pandey, Co-founder of PlatinumRx. "For patients managing chronic conditions like diabetes or heart disease, medicines are an essential part of everyday life. Even modest savings on monthly prescriptions can add up to a meaningful difference over the years. Our goal has always been to make quality medicines more accessible and affordable. Seeing our customers collectively save more than Rs. 137 crore while placing their trust in PlatinumRx is a strong validation of that mission. We are only getting started."
PlatinumRx stated that it follows a rigorous quality framework by partnering exclusively with WHO-GMP certified manufacturing facilities. The company is also LegitScript certified, reinforcing its commitment to operating in accordance with global standards of compliance and patient safety. Unlike conventional procurement-led models, every medicine listed on the platform is evaluated and shortlisted by a dedicated team of qualified medical professionals. According to the company, this process ensures customers receive reliable, quality-assured branded generic alternatives that meet strict safety and manufacturing standards. The medical-first approach is intended to support patients undergoing long-term therapies by ensuring consistent access to affordable medicines.
Alongside affordability, PlatinumRx continues to strengthen medicine accessibility across India. The company currently fulfills nearly 60 per cent of its orders within 48 hours through a network of nine strategically located warehouses. To further enhance its nationwide logistics infrastructure, PlatinumRx is adding six new warehouses to improve delivery timelines and expand access to affordable medicines across additional regions.
"Making medicines affordable is only part of the solution—they also need to reach patients quickly and reliably," said Piyush Kumar, Co-founder of PlatinumRx. "Many patients rely on regular medicine refills for ongoing treatment, making timely delivery just as important as affordability. By expanding our warehouse network, we're strengthening our supply chain to improve delivery timelines and ensure quality medicines are available to more households across India."
PlatinumRx is an India-based branded generic medicine platform founded by Ashutosh Pandey and Piyush Kumar. The company offers quality-assured medicines manufactured in WHO-GMP certified facilities, curated by a team of qualified medical professionals, and operates with LegitScript certification. With a mission to make healthcare more affordable, PlatinumRx continues to help millions of Indians reduce their medicine expenses by providing trusted branded generic alternatives while expanding access to safe, high-quality treatments across the country.

Comment List